Stephen Mitchener
Geen lopende functies
Vermogen: 193 753 $ op 31-03-2024
Profiel
Stephen Mitchener worked as the Head of US Oncology Strategy, Partnering & Operations at Novartis Pharmaceuticals Corp.
from 2005 to 2018.
He then worked as the Chief Business Officer at Karyopharm Therapeutics, Inc. before becoming the Chief Business Officer & Senior Vice President at Axcella Health, Inc. from 2018 to 2020.
Mitchener holds a doctorate degree from The University of North Carolina at Charlotte.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-03-2023 | 128 313 ( 0.11% ) | 193 753 $ | 31-03-2024 |
Eerdere bekende functies van Stephen Mitchener
| Bedrijven | Functie | Einde |
|---|---|---|
| AXCA HEALPAR | Corporate Officer/Principal | 01-12-2020 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 01-08-2018 |
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Opleiding van Stephen Mitchener
| The University of North Carolina at Charlotte | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| AXCA HEALPAR | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
